Stage Ib2 cervical cancer patients need to receive chemotherapy and other adjuvant treatments if there are intermediate and high-risk factors such as lymph node positivity after surgery; if not, chemotherapy can be ignored for the time being.
Tumor diameter of patients with stage Ib2 cervical cancer is usually 2~4cm, and radical hysterectomy is the first treatment to be considered for this kind of patients. If there are high risk factors such as positive lymph nodes, positive surgical margins or positive paratesticular tumors in postoperative pathology, there are high chances of metastasis and recurrence, so chemotherapy needs to be considered.
Chemotherapy should also be considered if the tumor is ≥3.0 cm in diameter, or if it infiltrates more than 1/3 of the outside of the cervix, if the embolus is seen in the interstitial space of the cervix, or if it is pathologically characterized as adenocarcinoma or adenosquamous carcinoma, and if it has more than two of the above four intermediate risk factors.
Chemotherapy also has side effects, and if there are no such factors, chemotherapy is usually not needed, and it is recommended to consult a medical professional in a timely manner.